EditorsAbout the SiteComes vs. MicrosoftUsing This Web SiteSite ArchivesCredibility IndexOOXMLOpenDocumentPatentsNovellNews DigestSite NewsRSS

02.19.19

What Happened in the United States Now Happens in Europe: Lots of Patents Turn Out to Be Bunk, Fake, Bogus, Invalid and Thus Worthless

Posted in America, Courtroom, Europe, Law, Patents at 5:09 am by Dr. Roy Schestowitz

Low patent quality has done incredible harm/damage to confidence in the system

Cardboard recycling

Summary: Worthless patents — not opposition to such patents — are the greatest threat to the legitimacy of the patent system, yet bureaucrats fail to heed the warning in the name of short-term profits

HERE AT TECHRIGHTS we’ve been following the U.S. Patent and Trademark Office (USPTO) for more than a decade and a half (I wrote about it long before the site even existed). When I was about 20 I was upset to see Graffiti input on Palm being destroyed by patents. I wrote about it in my personal blog. Such ridiculous US patents could possibly be used by a relic like Xerox to embargo — e.g. via ITC — devices I so often used (I still own and use a Palm PDA). The workaround was known as Graffiti 2, which is vastly inferior. The PDA I use was manufactured in 2003 — the same year Graffiti 2 was introduced, so I’m lucky to have dodged this sabotage by patents. For those who wonder what got me upset at such patents (software patents), that was it. Richard Stallman often attributes the creation of GNU and then the FSF to Xerox printers that upset him. So I share more than my initials with him and we’ve been good friends. We share our views on patents and the European patent system.

Things have changed a lot since, especially in 2014 when SCOTUS ruled on Alice, giving rise to 35 U.S.C. § 101 as we now know it.

“We are saddened to see Europe falling into the same trap that the US had fallen into a few decades ago when the Federal Circuit gave a green light to software patents.”Seeing what happens in the US this year, we’re not even tempted to resume coverage of it. Virtually all cases are concluded the way we’d like them to. Janal Kalis (“Patent Buddy”) is still obsessing over mere patent applications, as PTAB and district courts have nothing for these patent maximalists to celebrate. This week he wrote: “The PTAB Reversed an Examiner’s 101 Rejection of Claims for a Method of Detecting Similar Objects” (the exception).

Usually it’s the other way around. We also note that patent extremists blame “big tech” for the demise of software patents, never mind if “small tech” (firms) too pushed towards that. “They ‘happen’ to be those who also produce a lot of software,” I replied to him, “unlike patent trolls and law firms, so…”

“It is impossible to argue (any longer) that the EPO has no patent quality issues; even the EPO’s management now admits it.”Readers can probably agree that what happened in the US after Alice, more so in recent years as caselaw shaped up, was overwhelmingly positive. Developers were able to focus on actual work rather than hire lawyers.

We are saddened to see Europe falling into the same trap that the US had fallen into a few decades ago when the Federal Circuit gave a green light to software patents. The European Patent Office (EPO) under the leadership of António Campinos is a very vocal booster of software patents in Europe. The managers at the Office, preoccupied and obsessed with so-called ‘production’, are still trying very hard to break the rules (e.g. misinterpret the EPC) and grant bogus patents — European Patents courts would reject such as "blockchain" patents.

The EPO has already admitted these are software patents as so does Bastian Best on Twitter, soon to be retweeted by EPO (official). The EPO reposted this yesterday: “For the blockchain enthusiasts in my network: Koen Lievens does a great job in this video explaining how #blockchain inventions can be #patent’ed at the @EPOorg. Hint: It’s the exact same standard as for any other type of CII.”

What are these people thinking? Bearing in mind the EPO's own admission of quality problems (albeit internally only, for now), shouldn’t they quit this madness? Sooner or later all these patents will fall in an avalanche like Alice in the US.

Meanwhile, judging by yesterday’s long post from IP Kat, the non-impartial and not-so-independent (i.e. partially dependent) EPO appeal boards are hard to rely on as long as Battistelli and Campinos, two crooked patent maximalists, control them. Watch this latest situation:

A recent decision by the EPO Technical Boards of Appeal (TBA) departed from previous boards on how the novelty of the increased purity of a known compound is to be assessed. In T 1085/13, the TBA diverged from previous decisions that established special criteria for determining the novelty of a claim directed to a known compound of increased purity. The decision also ignores the criteria set out in the EPO Guidelines for Examination. These state that to be novel a selection invention must be “purposive”. The decision therefore confirms that the EPO is prepared to depart from its previous positions on the criteria for assessing the novelty of selection inventions. It seems that, for the purpose of assessing novelty, the TBA are now in favour of applying the same novelty criteria to these inventions as to any other type of invention, and nothing further.

[...]

As far as this Kat is aware, T 1085/13 is the first decision by the TBA to depart from the “special criteria” for purity inventions provided in T 0990/96 (although she is happy to be corrected on this if readers are aware of any earlier decisions).

T 1085/13 also appears to have ignored the criteria for selection inventions established by earlier TBA (and outlined in the EPO guidelines for examination) that a claimed selection must constitute a “purposive selection”. This is in line with other recent decisions of the TBA. It therefore appears that the third criteria for the novelty of selection inventions is being phased out, although this is still not reflected in the most recent EPO Guidelines for Examination. If this really is to be the new position of the EPO, is it not time for these changes to be reflected in the guidelines? This Kat also awaits with interest to see whether this latest decision on purity inventions will be followed by subsequent boards and the Examiners.

Guidelines should be based on law, not so-called ‘production’ aspirations. This is akin to what Iancu does at the USPTO, in effect mimicking Battistelli. Judges are being pressured and condemned.

As further evidence of the decline of quality of patents (EPO and USPTO in this case), watch these two new reports (from yesterday) [1, 2] as they cover something we wrote about some days ago (based on the original press release). The gist of it is, the EPO admits it granted false patents… yet again (not just the USPTO, where such invalidation is a lot more common with Patent Trial and Appeal Board (PTAB) inter partes reviews (IPRs)).

To quote the first report:

The European Patent Office (EPO) and the US Patent and Trademark Office (USPTO) have both invalidated patents owned by Immunex Corporation.
The patents cover antibodies that target human interleukin-4 receptors.

Regeneron Pharmaceuticals had opposed the patents, arguing that European patent 2,990,420 and US patent 8,679,487 were invalid due to the insufficiency of disclosure.

The EPO invalidated Immunex’s European patent a day after the USPTO’s Patent Trial and Appeal Board invalidated all 17 claims of the US patent due to obviousness.

Joseph LaRosa, executive vice president of Regeneron, commented: “We applaud decisions by the US and European patent offices this week, which invalidate Immunex’s functional patent claims to antibodies that target human IL-4 receptors.”

The second such report says:

Regeneron Pharmaceuticals (Nasdaq: REGN) has announced two important legal developments invalidating Immunex patents with functional claims to antibodies that target human interleukin-4 receptors (IL-4R).

On Friday, the Opposition Division of the European Patent Office (EPO) revoked wholly-owned by Amgen (Nasdaq: AMGN) subsidiary Immunex’ European Patent No 2,990,420 in its entirety because the claims were invalid for insufficiency of disclosure. This follows a decision by the Patent Trial and Appeal Board (PTAB) of the US Patent & Trademark Office (USPTO) to invalidate all 17 claims of Immunex’ US Patent No 8,679,487 as obvious. These decisions are subject to appeal by Immunex.

Regeneron’s shares closed up 2.17% at $423.79 on Friday, while Amgen dipped 1.51% to $185.50 in after-hours trading.

“We applaud decisions by the US and European patent offices this week, which invalidate Immunex’ functional patent claims to antibodies that target human IL-4 receptors,” said Joseph LaRosa, executive vice president, general counsel and secretary, at Regeneron. “It is our position that Immunex’ functional claims unfairly attempt to claim ownership far beyond the molecules developed, and stifle innovation within the broader scientific community,” he added.

It is impossible to argue (any longer) that the EPO has no patent quality issues; even the EPO’s management now admits it.

Share this post: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Reddit
  • co.mments
  • DZone
  • email
  • Google Bookmarks
  • LinkedIn
  • NewsVine
  • Print
  • Technorati
  • TwitThis
  • Facebook

If you liked this post, consider subscribing to the RSS feed or join us now at the IRC channels.

Pages that cross-reference this one

What Else is New


  1. Links 22/2/2020: Polish Government Increases GNU/Linux Use, Samza 1.3.1

    Links for the day



  2. Being Rich Does Not Imply Being Smart (Especially When One is Born Into Wealth)

    Presenting the 'genius' (college dropout, but that does not matter when the yardstick of wisdom is wealth alone), with his own predictions overlaid on top of his photo from the show of Bloomberg (another 'genius' whose supposed brilliance is measured using money alone)



  3. The Rise and Fall of Free Software

    "We simply need to make the movement less corporate, and more grassroots."



  4. Why You Should Adopt Debian 10, Not Vista 10 (Windows Vista With Microsoft's Latest Surveillance Add-ons)

    A little personal story and recommendation of Debian "Buster" (10) or Devuan (whose developers persist)



  5. Ethics by Exclusion

    It's the same old philosophical question; can excluding those who are perceived to be intolerant be seen as an act of tolerance?



  6. Even Worse Than Microsoft Inside the Board of the OSI

    The OSI has accepted people from companies that actively attack Software Freedom and there may be more on their way



  7. ZDNet Continues to Stuff Its 'Linux' Section With Proprietary Software of Microsoft

    The above is what the "Linux" section of ZDNet is going to look like throughout the weekend (and this is hardly unusual, either)



  8. IRC Proceedings: Friday, February 21, 2020

    IRC logs for Friday, February 21, 2020



  9. Links 21/2/2020: EasyOS 2.2.11 Released, Microsoft's Control of the Linux Foundation Increases and More Binary Blobs Arrive

    Links for the day



  10. IRC Proceedings: Thursday, February 20, 2020

    IRC logs for Thursday, February 20, 2020



  11. Video: LinuxWorld 1999, Torvalds and Stallman

    LinuxWorld 1999, Torvalds and Stallman



  12. GNU World Order is a Personal Sacrifice, LinuxWorld Just Business

    As the Linux Foundation shows, Linux is just business (and proprietary software) as usual, software patents included, whereas it’s GNU that continues the Free Software Movement’s battles



  13. Links 20/2/2020: Oracle Solaris 11.4 SRU18, Mesa 20, VirtualBox 6.1.4

    Links for the day



  14. Open Source Did Not Win, It Was Assimilated to and by Proprietary Software

    Don’t fall for the whole “Open Source has won!” spiel; You know we’ve lost the battle (and were in effect gradually conquered) at OSI and elsewhere when those who speak for the OSI are Michael Cheng (Facebook), Max Sills (Google), and Chris Aniszczyk (Linux Foundation); they say “Open Source Under Attack” (FOSDEM talk) but their employers are the ones attacking and they downplay openwashing



  15. Former Microsoft Employees Don't Like Talking About Past and Present Microsoft Back Doors (Designed for Spy Agencies)

    In a typical Microsoftian fashion, once they cannot defend the illusion/delusion that Microsoft values security the 'Softers' run away and block any further debate



  16. Techrights Warns Against Impending Extradition Efforts (Passage of Julian Assange to His Death in the United States)

    Imprisonment of journalists who are effective at exposing crimes (of the powerful, not petty crimes) must never be condoned



  17. Team UPC: Many Mouths and No Ears

    The mental condition of Team UPC gets more worrisome by the week



  18. Team UPC Insults Judges Because the UPC is Dead and UPC Lobbyists Have Nothing Left to Lose

    More judge-shaming tactics are in the mix; Team UPC seems to feel like there's nothing left to lose as the UPC is already dead (hope itself is next to die)



  19. IRC Proceedings: Wednesday, February 19, 2020

    IRC logs for Wednesday, February 19, 2020



  20. China Bashing is Grounded in Fear (That They Can Simply Do Better Than the West)

    The atmosphere of hate towards China — fuelled partly by a white supremacist in the White House — is unhelpful and insulting; dignity and understanding is the way to go



  21. IRC Proceedings: Tuesday, February 18, 2020

    IRC logs for Tuesday, February 18, 2020



  22. FFII Press Release: Germany Can No Longer Ratify the Unitary Patent Due to Brexit and the Established AETR Case-law, says FFII

    Germany cannot ratify the current Unitary Patent due to Brexit and the established AETR case-law. The ratification of the UPC (Unified Patent Court) by Germany would constitute a violation of the AETR case-law, which was used during the EPLA negotiations in 2006 to consider a deal with non-EU countries, such as Switzerland.



  23. DRM (Proprietary Software) Already Makes Mozilla Firefox Broken, Unreliable, Undependable (Dependent on Binary Blobs)

    More people are beginning to realise that Mozilla resorted to self-harming DRM and self-inflicted damage that impacts Firefox; can Mozilla (re)join the anti-DRM coalitions?



  24. EPO and Other Patent Updates Over RSS

    Site syndication (over RSS feeds or XML/Atom) is vastly better than what became popular in recent years (censored, centralised, discriminatory "Social Control Media"); here are some feeds of interest



  25. When It Comes to a Unitary Patent System, Bad (or Intentionally Dishonest) Legal Advice Has Become the Norm

    The Unified Patent Court and Unitary Patent (UPC and UP, respectively) reinforce the old saying about lawyers being liars, doing anything to attract clients (to take their money); the UPC is basically dead, but fiction, falsehoods and outrageous fantasies still find their way into Web sites of law firms



  26. Links 19/2/2020: KDE Plasma 5.18.1, GNOME 3.36 Beta 2 and WordPress 5.4 Beta 2

    Links for the day



  27. Is Linux Foundation a Microsoft Branch Now?

    The so-called ‘Linux’ Foundation (LF) nowadays helps Microsoft cement its monopoly — the very opposite of what ages ago it said the LF would do



  28. Are Songs Property? And Maths Also Property? Artificial Monopolies Are Not Property...

    Patent maximalists continue to face stronger arguments from their sceptics, who rightly allege that words are being intentionally misused and numbers fabricated so as to distort underlying facts



  29. Battistelli Blocked Techrights at EPO (Banned for More Than 5 Years), So CEIPI Won't Respect Access to Information Either

    The use of censorship to confront people who talk about (not even expose) corruption isn't novel; but the adoption of this approach in Europe (not just places like Russia and China) is definitely noteworthy



  30. IRC Proceedings: Monday, February 17, 2020

    IRC logs for Monday, February 17, 2020


RSS 64x64RSS Feed: subscribe to the RSS feed for regular updates

Home iconSite Wiki: You can improve this site by helping the extension of the site's content

Home iconSite Home: Background about the site and some key features in the front page

Chat iconIRC Channel: Come and chat with us in real time

Recent Posts